Collectively, this study provides a genomic alteration-informed multiomics framework supporting VDAC1 as a mitochondrial-associated biomarker in PDAC and highlights its potential relevance for molecular characterization of pancreatic cancer. This evidence concerns the gene VDAC1 and familial pancreatic carcinoma.